Cargando…
Identification of Novel Biomarkers and Candidate Drug in Ovarian Cancer
This paper investigates the expression of the CREB1 gene in ovarian cancer (OV) by deeply excavating the gene information in the multiple databases and the mechanism thereof. In short, we found that the expression of the CREB1 gene in ovarian cancer tissue was significantly higher than that of norma...
Autores principales: | Li, Chia-Jung, Lin, Li-Te, Chu, Pei-Yi, Chiang, An-Jen, Tsai, Hsiao-Wen, Chiu, Yi-Han, Huang, Mei-Shu, Wen, Zhi-Hong, Tsui, Kuan-Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073701/ https://www.ncbi.nlm.nih.gov/pubmed/33921660 http://dx.doi.org/10.3390/jpm11040316 |
Ejemplares similares
-
Expression status and prognostic significance of mitochondrial dynamics OPA3 in human ovarian cancer
por: Tsai, Hsiao-Wen, et al.
Publicado: (2022) -
The Molecular Regulation in the Pathophysiology in Ovarian Aging
por: Li, Chia-Jung, et al.
Publicado: (2021) -
MicroRNA in Ovarian Cancer: Biology, Pathogenesis, and Therapeutic Opportunities
por: Chen, San-Nung, et al.
Publicado: (2019) -
Multi-Omics Analysis Identifying Key Biomarkers in Ovarian Cancer
por: Li, Ju-Yueh, et al.
Publicado: (2020) -
Phosphoglycerate mutase family member 5 maintains oocyte quality via mitochondrial dynamic rearrangement during aging
por: Li, Chia‐Jung, et al.
Publicado: (2022)